Obermatt
See Similar Stocks →

Uniphar

ISE:UPR · IE00BJ5FQX74
Health Care Providers & ServicesMedium

360

59
EV / EBIT37
Price / Owner Earnings17
Owner Earnings Yield42
Dividend Yield39
Price/Sales70
EV / Gross Profit72
Price/Book18
Return on Capital72
Cash Return on Capital53
Return on Equity72
EBIT Margin27
Gross Profitability57
Cash Conversion54
Accruals29
Owner Earnings Margin44
Sales growth48
Profit Growth41
Long-Term EPS Growth75
Owner Earnings Growth89
Reinvestment88
Price momentum65
Debt load35
Refinancing18
Debt Payback39
Liquidity54
Analyst ratings75
Opinion Changes50
Price Target Upside18
Market mood75
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Uniphar generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryIreland
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeISE
Founded1994
Employees738
Websiteuniphar.ie
ISINIE00BJ5FQX74
Last UpdateApr 2, 2026
Indices
ISEQ (Ireland)Sound Pay Practices (Europe)
Themes
Digital WellnessHealth DiagnosticsPharmacovigilanceInformation TechnologyRetail

Description

Uniphar PLC operates as a pharmaceutical services and supply chain management company. The company provides comprehensive solutions to manufacturers, healthcare professionals, and patients, enhancing healthcare delivery through innovative approaches…

Analysis

Middle-of-the-road

Uniphar plc is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 28.3× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 11% yearly growth; analysts expect 15%. The price, in other words, assumes less than the experts do.

The trajectory is solid and the balance sheet is adequate. The company scores 14/20 on our value-creation score: strong value creator.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
41
2023202420252026

All-time high

50

Jan 2026

All-time low

6

Apr 2023

Average rank

30

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
70
85
83
77
Price/Earnings
17
59
53
33
Price/Book
18
91
84
82
Dividend Yield
39
26
33
28
Value (overall)
17
50
66
72

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Uniphar with its peers
CVS Group
LSE:CVSG
79
CountryUK
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Medios
GER:ILM1
98
CountryGermany
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Fresenius
GER:FRE
49
CountryGermany
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Amarin Corporation
NAQ:AMRN
53
CountryIreland
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Galenica
SWX:GALE
29
CountrySwitzerland
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Medicover
STO:MCOV B
21
CountryCyprus
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →